Granahan Investment Management’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-84,013
Closed -$525K 188
2023
Q3
$525K Sell
84,013
-221,980
-73% -$962K 0.02% 175
2023
Q2
$1.33M Buy
305,993
+89,490
+41% +$199K 0.04% 164
2023
Q1
$368K Buy
216,503
+2,833
+1% +$5K 0.01% 162
2022
Q4
$415K Buy
213,670
+117,175
+121% +$263K 0.01% 169
2022
Q3
$190K Sell
96,495
-137,611
-59% -$328K 0.01% 173
2022
Q2
$478K Sell
234,106
-61,641
-21% -$153K 0.02% 172
2022
Q1
$1.04M Buy
295,747
+241,793
+448% +$859K 0.03% 171
2021
Q4
$209K Sell
53,954
-108,821
-67% -$514K ﹤0.01% 185
2021
Q3
$1.01M Sell
162,775
-115,477
-42% -$985K 0.02% 187
2021
Q2
$3.28M Buy
278,252
+110,894
+66% +$1.28M 0.06% 172
2021
Q1
$2.65M Buy
+167,358
New +$3.01M 0.06% 164

Other funds holding LFMD

Granahan Investment Management's LFMD Position: Q4 2023 in Review

Granahan Investment Management sold out of LifeMD (LFMD) in Q4 2023, closing a stake of 84,013 shares — an estimated $525K sold.

Granahan Investment Management first reported a position in LFMD in Q1 2021 and held it in 11 quarters. The position peaked at $3.28M in Q2 2021. 84 funds tracked by Wall St. Rank hold LFMD as of Q4 2023.

  • Granahan Investment Management reported no remaining LifeMD position as of Q4 2023 after selling out during the quarter.
  • Granahan Investment Management sold 84,013 LifeMD shares in Q4 2023, an estimated $525K.
  • Granahan Investment Management first reported a position in LifeMD in Q1 2021 and held it in 11 quarters.
  • Granahan Investment Management's LifeMD position peaked at $3.28M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held LifeMD as of Q4 2023.

Based on Granahan Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.